Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center()

The current study aimed to examine the impact of COVID-19 pandemic on patient-related delay with ST-segment elevation myocardial infarction (STEMI) at a tertiary center in the United Kingdom. The study demonstrated a significant delay in symptom-to-first medical contact and a higher cardiac troponin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelaziz, Hesham K., Abdelrahman, Amr, Nabi, Amjad, Debski, Maciej, Mentias, Amgad, Choudhury, Tawfiq, Patel, Billal, Saad, Marwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211651/
https://www.ncbi.nlm.nih.gov/pubmed/32497914
http://dx.doi.org/10.1016/j.ahj.2020.04.022
Descripción
Sumario:The current study aimed to examine the impact of COVID-19 pandemic on patient-related delay with ST-segment elevation myocardial infarction (STEMI) at a tertiary center in the United Kingdom. The study demonstrated a significant delay in symptom-to-first medical contact and a higher cardiac troponin-I level on admission in patients with STEMI during the COVID-19 pandemic versus the pre-COVID era.

Ejemplares similares